Related Experiment Video
Updated: Nov 16, 2025

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Primary Immunodeficiency Diseases in Iran: Past, Present and Future
Asghar Aghamohammadi1,2, Hassan Abolhassani1,2, Nima Rezaei1,2,3
1Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Clinical immunology in Iran has advanced significantly over 40 years, with key developments in primary immunodeficiency (PID) diagnosis and treatment. This review highlights historical milestones, current challenges, and future directions for PID management.
Area of Science:
- Medical Science
- Immunology
- Public Health
Background:
- Clinical immunology is an emerging field in Iran and other developing nations.
- The late 1970s marked a turning point for primary immunodeficiency (PID) diagnosis and treatment.
- The establishment of the Division of Clinical Immunology and Allergy at Tehran's Children's Medical Center was a pivotal moment.
Purpose of the Study:
- To review the historical evolution of clinical immunology in Iran.
- To identify current challenges in the field of primary immunodeficiency.
- To outline future directions for the management of immunodeficiency diseases.
Main Methods:
- This study is a review of historical events and developments.
- It synthesizes information on the progress of clinical immunology in Iran.
- The review focuses on key milestones in PID management.
Main Results:
- Significant advancements in PID diagnosis and treatment have occurred over the past 40 years.
- Key developments include fellowship programs, a national registry, a research center, and a national network for PID.
- These initiatives have transformed disease management in Iran.
Conclusions:
- The field of clinical immunology in Iran has experienced substantial growth.
- Addressing current challenges is crucial for continued progress in PID management.
- Strategic future directions are essential for improving patient outcomes in primary immunodeficiency.
More Related Videos
08:57Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
14:14Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR
Published on: December 6, 2014
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...